A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma

Clinical trial NCT01917383 · COMPLETED

Trial details

NCT number: NCT01917383
Sponsor: Inotek Pharmaceuticals Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Start date: 2013-08-01
Primary completion: 2014-08-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.